Management of Occupational and Nonoccupational HIV Exposure

  • Author: Christopher B. Hurt, MD (More Info)
  • Editors In Chief: Daniel R. Kuritzkes, MD; Joseph J. Eron, Jr., MD
  • Last Reviewed: 8/1/18 (What's New)

Summary

  • Observational surveillance data revealed zidovudine use following occupational exposure associated with 81% reduction in odds of HIV infection
  • Exposures with greatest risk of seroconversion include use of large-gauge needles, deep-penetrating injuries with or without bleeding, procedures involving arteries or veins, visible blood on device causing the injury, and injuries sustained during emergency procedure[Cardo 1997]

Action required

©2020 Clinical Care Options, LLC. All Rights Reserved.

The materials published via inPractice® reflect the views of the reviewers or authors of the material, not those of Clinical Care Options, LLC, the accredited provider, or the companies providing educational grants. The materials may discuss uses and dosages for therapeutic products that have not been approved by the United States Food and Drug Administration. A qualified healthcare professional should be consulted before using any therapeutic product discussed. Readers should verify all information and data before treating patients or using any therapies described in these materials.